EstechPharma Co. Ltd Cash Flow Conversion Efficiency
EstechPharma Co. Ltd cash flow conversion efficiency. Based on the latest financial reports, EstechPharma Co. Ltd (041910) has a cash flow conversion efficiency ratio of 0.018x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩2.38 Billion ≈ $1.61 Million USD) by net assets (₩135.93 Billion ≈ $92.12 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of EstechPharma Co. Ltd (2013–2025)
Cash flow conversion efficiency of EstechPharma Co. Ltd from 2013 to 2025. This chart illustrates how EstechPharma Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 041910 stock price for real-time trading data and today's change.
EstechPharma Co. Ltd Cash Flow Conversion Ratio Explained
EstechPharma Co. Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
EstechPharma Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of EstechPharma Co. Ltd ranked by their cash flow conversion efficiency. Also see EstechPharma Co. Ltd market cap and net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Elron Electronic Industries Ltd
TA:ELRN
|
-0.005x |
|
Adaptimmune Therapeutics plc
F:473A
|
0.490x |
|
Oceanpal Inc
NASDAQ:OP
|
-0.007x |
|
OS Therapies Incorporated
NYSE MKT:OSTX
|
-1.000x |
|
Rank Progress S.A.
WAR:RNK
|
0.006x |
|
Brunswick Exploration Inc
V:BRW
|
-0.040x |
|
Golden House
TA:GOHO
|
0.010x |
|
FRANCHETTI S.P.A.
F:D0E
|
N/A |
Annual Cash Flow Conversion Efficiency for EstechPharma Co. Ltd (2013–2025)
The table below shows the annual cash flow conversion efficiency of EstechPharma Co. Ltd from 2013 to 2025. Review cash generation quality of EstechPharma Co. Ltd to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩135.93 Billion ≈ $92.12 Million |
₩8.83 Billion ≈ $5.99 Million |
0.065x | +5.33% |
| 2024-12-31 | ₩128.58 Billion ≈ $87.14 Million |
₩7.93 Billion ≈ $5.38 Million |
0.062x | +48.95% |
| 2023-12-31 | ₩115.63 Billion ≈ $78.36 Million |
₩4.79 Billion ≈ $3.25 Million |
0.041x | +391.41% |
| 2022-12-31 | ₩116.09 Billion ≈ $78.67 Million |
₩-1.65 Billion ≈ $-1.12 Million |
-0.014x | -390.39% |
| 2021-12-31 | ₩123.30 Billion ≈ $83.56 Million |
₩603.42 Million ≈ $408.93K |
0.005x | -88.42% |
| 2020-12-31 | ₩111.39 Billion ≈ $75.49 Million |
₩4.71 Billion ≈ $3.19 Million |
0.042x | +1.21% |
| 2019-12-31 | ₩102.72 Billion ≈ $69.61 Million |
₩4.29 Billion ≈ $2.91 Million |
0.042x | -48.58% |
| 2018-12-31 | ₩89.25 Billion ≈ $60.48 Million |
₩7.25 Billion ≈ $4.91 Million |
0.081x | -4.26% |
| 2017-12-31 | ₩82.38 Billion ≈ $55.83 Million |
₩6.99 Billion ≈ $4.74 Million |
0.085x | -19.76% |
| 2016-12-31 | ₩77.42 Billion ≈ $52.47 Million |
₩8.19 Billion ≈ $5.55 Million |
0.106x | -27.10% |
| 2015-12-31 | ₩72.13 Billion ≈ $48.88 Million |
₩10.46 Billion ≈ $7.09 Million |
0.145x | +120.71% |
| 2014-12-31 | ₩75.99 Billion ≈ $51.50 Million |
₩4.99 Billion ≈ $3.38 Million |
0.066x | -56.18% |
| 2013-12-31 | ₩67.96 Billion ≈ $46.05 Million |
₩10.19 Billion ≈ $6.91 Million |
0.150x | -- |
About EstechPharma Co. Ltd
EstechPharma Co., Ltd. manufactures and sells pharmaceuticals products. It also offers raw materials, such as RBM and PLK. The company was formerly known as Estech Chemical and changed its name to EstechPharma Co., Ltd. in January 2001. EstechPharma Co., Ltd. was founded in 1996 and is headquartered in Hwaseong-si, South Korea.